Observer

The title, “Does the Flower Hear the Bee?”, came to the curator as she thought about the many systems of communication and interchange that exist in nature.

Observer caught up with Siyang-Le to find out what to expect from the upcoming edition and to hear more about Art Basel's expanding role in Asia.

As the FDA prepares to regulate A.I. in drug development, biotech startups and pharma giants are racing to harness its potential for faster, more precise drug discovery.

From elegant baubles and glamorous shoes to indulgent cashmere and tasteful accessories, here’s what to buy the most fashionable woman you know.

In this scathing review, Rex Reed rips into Hugh Grant’s misguided attempt at horror, describing the film as a “pointless screamfest” that’s more ideology lecture than thriller. The verdict? …

This prequel to the blockbuster films centers on a mysterious organization called the Sisterhood.

As Trump vows to dismantle key regulations, the U.S. A.I. Safety Institute argues that true innovation needs oversight as A.I. risks grow.

Being able to immerse herself in art is, she says, one of the highlights of her job.

She won this year's Sigg Prize for 'Alvinella Ophish,' an interdisciplinary project at the intersection of biotechnology, artificial intelligence and contemporary art.

COO Richard Thayer says Chelsea Art Fair will offer an intimate in-person experience for younger collectors that brings the company's thoughtfully curated online offerings to life.